We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Expanding the Spectrum of Stress-Induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures (CONDSIAS).
- Authors
Lindskov, Filippa Orlien; Karlsson, William Kristian; Skovbølling, Sara Lyngby; Nielsen, Emilie Neerup; Dunø, Morten; Stokholm, Jette; Henriksen, Otto Mølby; Langkilde, Annika Reynberg; Nielsen, Jørgen Erik
- Abstract
Stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (CONDSIAS) is an extremely rare, autosomal recessive neurodegenerative disorder. It is caused by biallelic pathogenic variants in the ADPRS gene, which encodes an enzyme involved in DNA repair, and is characterized by exacerbations in relation to physical or emotional stress, and febrile illness. We report a 24-year-old female, who was compound heterozygous for two novel pathogenic variants revealed by whole exome sequencing. Additionally, we summarize the published cases of CONDSIAS. In our patient, onset of symptoms occurred at 5 years of age and consisted of episodes of truncal dystonic posturing, followed half a year later by sudden diplopia, dizziness, ataxia, and gait instability. Progressive hearing loss, urinary urgency, and thoracic kyphoscoliosis ensued. Present neurological examination revealed dysarthria, facial mini-myoclonus, muscle weakness and atrophy of hands and feet, leg spasticity with clonus, truncal and appendicular ataxia, and spastic-ataxic gait. Hybrid [18F]-fluorodeoxyglucose (FDG) positron emission tomography/magnetic resonance imaging (PET/MRI) of the brain revealed cerebellar atrophy, particularly of the vermis, with corresponding hypometabolism. MRI of the spinal cord showed mild atrophy. After informed consent from the patient, we initiated experimental, off-label treatment with minocycline, a poly-ADP-polymerase (PARP) inhibitor, which has shown beneficial effects in a Drosophila fly model. The present case report expands the list of known pathogenic variants in CONDIAS and presents details of the clinical phenotype. Future studies will reveal whether PARP inhibition is an effective treatment strategy for CONDIAS.
- Subjects
SEIZURES (Medicine); INFORMED consent (Medical law); MYOCLONUS; ATAXIA; HEARING disorders; POSITRON emission tomography; SPINOCEREBELLAR ataxia
- Publication
Cerebellum, 2024, Vol 23, Issue 2, p861
- ISSN
1473-4222
- Publication type
Case Study
- DOI
10.1007/s12311-023-01582-w